HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan · Delayed Price · Currency is TWD

42.90

-0.05 (-0.12%)

Aug 19, 2026, 1:30 PM CST

HeXun Biosciences Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	308.21	293.23	286.42	130.57	49.47	-
Revenue Growth	1.24%	2.38%	119.36%	163.94%	-	-
Gross Profit	280.37	266.28	260.67	113.73	44.61	-
Operating Income	130.56	118.01	155.73	27.37	-8.98	-50.66
Net Income	116.33	111.91	147.22	33.49	-5.19	-42.99
Earnings Per Share	2.52	2.43	3.20	0.74	-0.14	-1.41
EPS Growth	-11.55%	-24.06%	332.90%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Taiwan	282.49	282.49	286.42	130.57	49.47
Other	10.74	10.74	-	-	-
Total	293.23	293.23	286.42	130.57	49.47

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	828.93	509.63	372.99	329.67	191.74	85.03
Total Debt	34.61	36.58	35.02	72.61	71.64	74.1
Net Cash (Debt)	794.32	473.05	337.97	257.06	120.11	10.93
Net Cash Growth	100.78%	39.97%	31.47%	114.03%	999.17%	-
Net Cash Per Share	17.22	10.28	7.34	5.67	3.20	0.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	163.8	163.89	120.92	43.09	11.23	-35.5
Capital Expenditures	-29.24	-27.29	-37.29	-20.67	-1.23	-
Free Cash Flow	134.56	136.61	83.63	22.42	10	-35.5
Free Cash Flow Growth	-11.72%	63.36%	272.98%	124.19%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.97%	90.81%	91.01%	87.10%	90.18%	-
Operating Margin	42.36%	40.24%	54.37%	20.96%	-18.15%	-
Pretax Margin	45.82%	42.95%	56.38%	25.65%	-10.49%	-
Profit Margin	37.74%	38.16%	51.40%	25.65%	-10.49%	-
FCF Margin	43.66%	46.59%	29.20%	17.17%	20.22%	-

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.220	0.220
Dividend Per Share Growth	0%	-
Dividend Yield	0.51%	0.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.04	25.90	21.09	89.01	-	-
P/FCF Ratio	16.64	21.21	37.13	132.95	-	-
PS Ratio	7.26	9.88	10.84	22.83	-	-